Nutritional status and survival of 8247 cancer patients

Dietary standing and survival of 8247 most cancers sufferers with or with out diabetes mellitus-results from a potential cohort examine

Background: The variety of most cancers sufferers with diabetes mellitus (DM) is steadily rising. Little is thought in regards to the dietary standing of this inhabitants. This examine characterised the dietary standing and survival of most cancers sufferers with diabetes in contrast with these with out diabetes.
Strategies: A complete of 8247 most cancers sufferers had been prospectively enrolled from 72 hospitals in China and adopted till August 2019. A worldwide estimation of the dietary standing was carried out for every participant utilizing standardized instruments. The outcomes had been cancer-specific survival (CSS) and general survival (OS).
Outcomes: The incidence of diabetes was 7.6% in the entire inhabitants. Compared with the non-DM group, the DM group had larger physique weight, however the same fat-free mass, a decrease handgrip energy and a decreased Karnofsky efficiency rating. A better proportion of sufferers with diabetes had been chubby/overweight as indicated by BMI. The proportion of sufferers who had been prone to malnutrition (evaluated by PG-SGA) was larger within the DM group (rating ≥ 4, 56.7% vs 52.9%). Sufferers with DM confirmed a worse CSS (4-year CSS, 62% vs 73%) and OS (4-year OS 39% vs 52%). Diabetes was related to an elevated threat of each cancer-specific (hazard ratio (HR) = 1.282, 95% confidence interval (CI) 1.070-1.536) and general (HR = 1.206, 95% CI 1.040-1.399) mortality.
Conclusions: Most cancers sufferers with diabetes had a bigger physique mass however decrease muscle energy, poorer efficiency standing and better incidence of malnourishment. Diabetes was related to compromised survival. Tailor-made dietary intervention is important for this subpopulation of sufferers.

.

ijddc
ijddc

VEGF-A(VEGF/1063) Antibody
BNC801063-500 500uL
EUR 652.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF680 conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNC811063-100 100uL
EUR 238.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF680R conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNC811063-500 500uL
EUR 652.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF680R conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNC701063-100 100uL
EUR 238.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF770 conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNC701063-500 500uL
EUR 652.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF770 conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNC881063-100 100uL
EUR 238.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF488A conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNC881063-500 500uL
EUR 652.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF488A conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNC051063-100 100uL
EUR 238.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF405M conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNC051063-500 500uL
EUR 652.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF405M conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNC041063-100 100uL
EUR 238.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF405S conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNC041063-500 500uL
EUR 652.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF405S conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNC401063-100 100uL
EUR 238.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF640R conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNC401063-500 500uL
EUR 652.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF640R conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNCB1063-100 100uL
EUR 238.8
Description: Primary antibody against VEGF-A(VEGF/1063), Biotin conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNCB1063-500 500uL
EUR 652.8
Description: Primary antibody against VEGF-A(VEGF/1063), Biotin conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNCAP1063-100 100uL
EUR 238.8
Description: Primary antibody against VEGF-A(VEGF/1063), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNCAP1063-500 500uL
EUR 652.8
Description: Primary antibody against VEGF-A(VEGF/1063), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNCA1063-250 250uL
EUR 459.6
Description: Primary antibody against VEGF-A(VEGF/1063), APC conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNCR1063-250 250uL
EUR 459.6
Description: Primary antibody against VEGF-A(VEGF/1063), RPE conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNCP1063-250 250uL
EUR 459.6
Description: Primary antibody against VEGF-A(VEGF/1063), PerCP conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNUM1063-50 50uL
EUR 474
Description: Primary antibody against VEGF-A(VEGF/1063), 1mg/mL

VEGF-A(VEGF/1063) Antibody
BNCH1063-100 100uL
EUR 238.8
Description: Primary antibody against VEGF-A(VEGF/1063), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNCH1063-500 500uL
EUR 652.8
Description: Primary antibody against VEGF-A(VEGF/1063), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNUB1063-100 100uL
EUR 250.8
Description: Primary antibody against VEGF-A(VEGF/1063), Concentration: 0.2mg/mL

VEGF-A(VEGF/1063) Antibody
BNUB1063-500 500uL
EUR 549.6
Description: Primary antibody against VEGF-A(VEGF/1063), Concentration: 0.2mg/mL

VEGF-A(VEGF/1063) Antibody
BNC611063-100 100uL
EUR 238.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF660R conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNC611063-500 500uL
EUR 652.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF660R conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNC551063-100 100uL
EUR 238.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF555 conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNC551063-500 500uL
EUR 652.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF555 conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNC431063-100 100uL
EUR 238.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF543 conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNC431063-500 500uL
EUR 652.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF543 conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNC681063-100 100uL
EUR 238.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF568 conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNC681063-500 500uL
EUR 652.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF568 conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNC471063-100 100uL
EUR 238.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF647 conjugate, Concentration: 0.1mg/mL

VEGF-A(VEGF/1063) Antibody
BNC471063-500 500uL
EUR 652.8
Description: Primary antibody against VEGF-A(VEGF/1063), CF647 conjugate, Concentration: 0.1mg/mL

Anti-VEGF/Vegfa Antibody
A00045 100ug/vial
EUR 352.8

Anti-VEGF/Vegfa Antibody
A00045-2 100ug/vial
EUR 352.8

Anti-VEGF/VEGFA Antibody
PB9071 100ug/vial
EUR 400.8

Anti-VEGF/VEGFA Antibody
PA1080 100ug/vial
EUR 400.8

VEGF antibody
10-2585 250 ug
EUR 590.4
Description: Mouse monoclonal VEGF antibody

VEGF antibody
10-2586 100 ug
EUR 289.2
Description: Mouse monoclonal VEGF antibody

VEGF antibody
10R-7735 500 ug
EUR 678
Description: Mouse monoclonal VEGF antibody

VEGF antibody
10R-V101ax 100 ug
EUR 571.2
Description: Mouse monoclonal VEGF antibody

VEGF antibody
10R-V101b 200 ug
EUR 805.2
Description: Mouse monoclonal VEGF antibody

VEGF antibody
10R-V109A 500 ug
EUR 327.6
Description: Mouse monoclonal VEGF antibody

VEGF antibody
70R-VG001 100 ug
EUR 392.4
Description: Affinity purified Goat polyclonal VEGF antibody

VEGF antibody
70R-VR001x 50 ug
EUR 392.4
Description: Affinity purified Rabbit polyclonal VEGF antibody

VEGF antibody
70R-VR003 50 ug
EUR 327.6
Description: Affinity purified Rabbit polyclonal VEGF antibody

VEGF antibody
70R-VR004 50 ug
EUR 327.6
Description: Affinity purified Rabbit polyclonal VEGF antibody

VEGF antibody
70R-VR006 50 ug
EUR 327.6
Description: Affinity purified Rabbit polyclonal VEGF antibody

VEGF antibody
70-VR20 50 ug
EUR 392.4
Description: Affinity purified Rabbit polyclonal VEGF antibody

VEGF antibody
70R-11863 100 ul
EUR 536.4
Description: Goat polyclonal VEGF antibody

VEGF antibody
70R-11864 100 ug
EUR 483.6
Description: Rabbit polyclonal VEGF antibody

VEGF Antibody
5363-100 each
EUR 398.4

VEGF Antibody
5363-30T each
EUR 175.2

VEGF Antibody
5365-100 each
EUR 379.2

VEGF Antibody
5365-30T each
EUR 175.2

VEGF antibody
70R-12327 100 ug
EUR 483.6
Description: Rabbit polyclonal VEGF antibody

VEGF antibody
70R-12328 100 ug
EUR 483.6
Description: Rabbit polyclonal VEGF antibody

VEGF antibody
70R-12329 100 ug
EUR 483.6
Description: Rabbit polyclonal VEGF antibody

VEGF antibody
70R-13764 100 ug
EUR 418.8
Description: Affinity purified Rabbit polyclonal VEGF antibody

VEGF Antibody
48707-100ul 100ul
EUR 399.6

VEGF Antibody
48707-50ul 50ul
EUR 286.8

VEGF Antibody
ABF5131 100 ug
EUR 525.6

VEGF antibody
PAab09933 100 ug
EUR 463.2

VEGF Antibody
R31500 100 ug
EUR 356.15
Description: VEGF is the only mitogen that specifically acts on endothelial cells. It may be a major regulator of tumor angiogenesis in vivo. It is structurally related to platelet-derived growth factor. VEGF shares homology with the PDGF A chain and B chain, including conservation of all 8 cysteines found in PDGFA and PDGFB. VEGF gene contains 8 exons. VEGF induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. And this gene also can regulate haematopoietic stem cell survival by an internal autocrine loop mechanism. What’s more, it also stimulates neurogenesis in vitro and in vivo.

VEGF Antibody
V8154-100UG 100 ug
EUR 349.3
Description: This mAb recognizes proteins of 19-22kDa (reducing) and 38kDa-44kDa (non-reducing), identified as various isoforms of Vascular Endothelial Growth Factor or Vascular Permeability Factor (VEGF/VPF). It is highly specific to VEGF, which is a homodimeric, disulfide-linked glycoprotein with a close homology to platelet-derived growth factor (PDGF). There are multiple isoforms of VEGF containing 206-, 189-, 165-, and 121-amino acid residues. The smaller two isoforms, VEGF165 and VEGF121, are secreted proteins and act as diffusible agents, whereas the larger two remain cell associated. VEGF/VPF plays an important role in angiogenesis, which promotes tumor progression and metastasis.

VEGF Antibody
V8154-20UG 20 ug
EUR 153.3
Description: This mAb recognizes proteins of 19-22kDa (reducing) and 38kDa-44kDa (non-reducing), identified as various isoforms of Vascular Endothelial Growth Factor or Vascular Permeability Factor (VEGF/VPF). It is highly specific to VEGF, which is a homodimeric, disulfide-linked glycoprotein with a close homology to platelet-derived growth factor (PDGF). There are multiple isoforms of VEGF containing 206-, 189-, 165-, and 121-amino acid residues. The smaller two isoforms, VEGF165 and VEGF121, are secreted proteins and act as diffusible agents, whereas the larger two remain cell associated. VEGF/VPF plays an important role in angiogenesis, which promotes tumor progression and metastasis.

VEGF Antibody
V8154SAF-100UG 100 ug
EUR 349.3
Description: This mAb recognizes proteins of 19-22kDa (reducing) and 38kDa-44kDa (non-reducing), identified as various isoforms of Vascular Endothelial Growth Factor or Vascular Permeability Factor (VEGF/VPF). It is highly specific to VEGF, which is a homodimeric, disulfide-linked glycoprotein with a close homology to platelet-derived growth factor (PDGF). There are multiple isoforms of VEGF containing 206-, 189-, 165-, and 121-amino acid residues. The smaller two isoforms, VEGF165 and VEGF121, are secreted proteins and act as diffusible agents, whereas the larger two remain cell associated. VEGF/VPF plays an important role in angiogenesis, which promotes tumor progression and metastasis.

VEGF/ Rat VEGF ELISA Kit
ELA-E0143r 96 Tests
EUR 1063.2

VEGF
MO15067 500 ug
EUR 1092

VEGF
LF-PR009 10 ug
EUR 306
Description: VEGF protein

VEGF
PR15028 10 ug
EUR 553.2

VEGF 121
PR15029 5 ug
EUR 498

VEGF 162
PR15030 25 ug
EUR 553.2

VEGF 165
PR15031 50 ug
EUR 1477.2

VEGF 120
PR15033 5 ug
EUR 459.6

VEGF 164
PR15034 25 ug
EUR 1352.4

VEGF 164
PR15035 50 ug
EUR 1477.2

Human VEGF 121 Antibody
32562-05111 150 ug
EUR 313.2

Human VEGF 165 Antibody
32563-05111 150 ug
EUR 313.2

EG VEGF antibody
20R-1607 100 ug
EUR 807.6
Description: Rabbit polyclonal EG VEGF antibody

VEGF C antibody
20R-1831 100 ug
EUR 807.6
Description: Goat polyclonal VEGF C antibody

EG VEGF antibody
70R-EG002 50 ug
EUR 327.6
Description: Affinity purified Goat polyclonal EG VEGF antibody

VEGF-C Antibody
5633-100 each
EUR 444

VEGF-C Antibody
5633R-100 each
EUR 379.2

VEGF-C Antibody
5633R-30T each
EUR 175.2

VEGF-C Antibody
5634-100 each
EUR 379.2

VEGF-C Antibody
5634-30T each
EUR 175.2

Impression of diabetes mellitus on feminine topics present process transcatheter aortic valve implantation: Insights from the WIN-TAVI worldwide registry

Background: Feminine topics represent half of all transcatheter aortic valve implantation (TAVI) candidates, however the affiliation between necessary comorbidities resembling diabetes mellitus (DM) and medical outcomes after TAVI stays unclear on this group.
Methodology: WIN-TAVI is a real-world worldwide registry of solely feminine topics present process TAVI. The examine inhabitants was stratified into these with (DM) and people with out DM (NDM). Valve Educational Analysis Consortium (VARC)-2 efficacy (composite of all-cause dying, stroke, myocardial infarction, hospitalization for valve-related signs or worsening congestive coronary heart failure, or valve-related dysfunction) was the first endpoint for this evaluation.
Outcomes: Of the 1012 topics included on this examine, 264 (26.1%) had DM at baseline. DM sufferers had been youthful however had a better burden of comorbidities. There have been no variations in VARC-2 efficacy occasions between DM and NDM sufferers at 30 days or 1 yr. Conversely, sufferers with DM had a decrease threat of VARC-2 life threatening bleeding at 30 days and 1 yr after TAVI in comparison with NDM sufferers, which remained important even after multivariable adjustment (HR, 0.34, 95% CI, 0.12-0.99; p = .047). Within the subgroup evaluation, insulin-dependent DM was not related to an elevated threat of hostile outcomes.
Conclusions: Amongst feminine sufferers present process TAVI, greater than one-fourth of the themes offered with DM. At 1-year follow-up, DM was related to decrease bleeding issues and no improve within the threat of different hostile occasions, together with mortality, after TAVI.

The Position of Diabetes Mellitus as an Impact Modifier of the Affiliation Between Smoking Cessation and Its Medical Prognoses: An Observational Cohort Research

The smoker’s paradox refers to an elevated threat of hostile medical outcomes after smoking cessation in sufferers with coronary artery illness. The mechanisms concerned are controversial. The current examine evaluated the impact of delay in smoking cessation on medical outcomes amongst sufferers after percutaneous coronary intervention (PCI) stratified by diabetes mellitus (DM). Sufferers included on this examine got here from a longtime Fu Wai hospital PCI cohort. Smoking conduct was recorded; medical finish factors included all-cause mortality and repeat revascularization.
The analyses had been based mostly on 8489 people who smoke who underwent PCI. Sufferers with and with out DM had been examined individually. Multivariable mannequin evaluation urged that smoking cessation was related to important decrease all-cause mortality each for non-DM and DM sufferers. The smoking paradox was noticed for revascularization. Nonetheless, the elevated threat of repeat revascularization correlated with quitting time amongst non-DM sufferers solely, particularly in the event that they stopped smoking late (>90 days) after their index process (adjusted hazard ratio, 3.40; 95% CI: 2.45-4.72). In conclusion, smoking cessation is related to a decrease mortality fee for PCI sufferers. Nonetheless, the relative profit on repeated revascularization was solely noticed amongst non-DM sufferers in the event that they stop smoking early.

GRO, KC, CXCL1, rRtGRO, rat
RC352-12 5ug
EUR 125.26

Mouse CXC-chemokine ligand 1(CXCL1/KC)ELISA Kit
YLA0122MO-48T 48T
EUR 465

Mouse CXC-chemokine ligand 1(CXCL1/KC)ELISA Kit
YLA0122MO-96T 96T
EUR 600

GRO/KC (CXCL1), Rat Recombinant
P1288-25 each
EUR 444

GRO/KC (CXCL1), Rat Recombinant
P1288-5 each
EUR 210

Recombinant Murine KC (CXCL1) Protein
PROTP12850-2 20ug
EUR 380.4
Description: All three isoforms of GRO are CXC chemokines that can signal through the CXCR1 or CXCR2 receptors. The GRO proteins chemoattract and activate neutrophils and basophils. Recombinant murine KC is a 7.8 kDa protein consisting of 72 amino acids including the 'ELR' motif common to the CXC chemokine family that bind to CXCR1 or CXCR2.

Recombinant Rat GRO/KC (CXCL1) Protein
PROTP14095-1 25ug
EUR 380.4
Description: All three isoforms of GRO are CXC chemokines that can signal through the CXCR1 or CXCR2 receptors. The GRO proteins chemoattract and activate neutrophils and basophils. Recombinant rat GRO/KC is a 7.8 kDa protein consisting of 72 amino acids including the 'ELR' motif common to the CXC chemokine family that bind to CXCR1 or CXCR2.

Rat CXCL1/CINC-1/KC ELISA Kit
RK00196 96 Tests
EUR 625.2

Rabbit Anti Mouse Cxcl1 Polyclonal Antibody
CPBT-65100RM 0.1 mg
EUR 1057.2

Mouse CXCL1 ELISA Kit
55R-1741 1 kit
EUR 748.8
Description: ELISA kit for detection of CXCL1 in the research laboratory

Mouse CXCL1 shRNA Plasmid
20-abx970673
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

GRO-alpha/CXCL1, Mouse
HY-P7188 50ug
EUR 639.6

ELISA kit for Mouse CXCL1
EK5299 96 tests
EUR 663.6
Description: Enzyme-linked immunosorbent assay kit for quantification of Mouse CXCL1 in samples from serum, plasma, tissue homogenates and other biological fluids.

Mouse CXCL1/GROα ELISA kit
LF-EK50473 1×96T
EUR 777.6

Mouse CXCL1 PicoKine ELISA Kit
EK0723 96 wells
EUR 547.2
Description: For quantitative detection of mouse CXCL1 in cell culture supernates and serum.

Mouse CXCL1 Detection Assay Kit
6725 1 kit
EUR 580.26
Description: Mouse CXCL1 Detection Assay Kit

CXCL1 protein (Mouse) (His tag)
80R-3368 50 ug
EUR 308.4
Description: Purified recombinant CXCL1 protein (Mouse) (His tag)

CXCL1 protein (Mouse) (His tag)
80R-3439 50 ug
EUR 308.4
Description: Purified recombinant CXCL1 protein (Mouse) (His tag)

Cxcl1 ORF Vector (Mouse) (pORF)
ORF042286 1.0 ug DNA
EUR 114

Mouse CXCL1 AssayLite Antibody (FITC Conjugate)
70027-05141 150 ug
EUR 513.6

CXCL1 ELISA Kit (Mouse) (OKBB00312)
OKBB00312 96 Tests
EUR 652.8
Description: Description of target: Chemokine (C-X-C motif) ligand 1 (CXCL1) is a small cytokine belonging to the CXC chemokine family that was previously called GRO1 oncogene, GROα, KC, Neutrophil-activating protein 3 (NAP-3) and melanoma growth stimulating activity, alpha (MSGA-α). In humans, this protein is encoded by the CXCL1 gene. The gene for CXCL1 is located on human chromosome 4 amongst genes for other CXC chemokines. The mature form of CXCL1 is maximally 73 amino acids long. CXCL1 is secreted by human melanoma cells, has mitogenic properties and is implicated in melanoma pathogenesis. CXCL1 is expressed by macrophages, neutrophils and epithelial cells, and has neutrophil chemoattractant activity. This chemokine elicits its effects by signaling through the chemokine receptor CXCR2.CXCL1 decreased the severity of multiple sclerosis and may offer a neuro-protective function. The standard product used in this kit is recombinant mouse CXCL1, consisting of 77 amino acids with the molecular mass of 8KDa.;Species reactivity: Mouse;Application: ELISA;Assay info: ;Sensitivity: < 1 pg/ml

CXCL1 ELISA Kit (Mouse) (OKAN04583)
OKAN04583 96 Wells
EUR 950.4
Description: Description of target: This gene encodes a protein that is a member of the CXC subfamily of chemokines. Chemokines, which recruit and activate leukocytes, are classified by function (inflammatory or homeostatic) or by structure. This secretory protein is proposed to bind the G-protein coupled receptor chemokine (C-X-C motif) receptor 2 to recruit neutrophils. In mouse, deficiency of this gene is associated with colitis and with defects in immune cell recruitment to the lung.;Species reactivity: Mouse;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 6.0 pg/mL

CXCL1 ELISA Kit (Mouse) (OKCD05712)
OKCD05712 96 Wells
EUR 730.8
Description: Description of target: This gene encodes a protein that is a member of the CXC subfamily of chemokines. Chemokines, which recruit and activate leukocytes, are classified by function (inflammatory or homeostatic) or by structure. This secretory protein is proposed to bind the G-protein coupled receptor chemokine (C-X-C motif) receptor 2 to recruit neutrophils. In mouse, deficiency of this gene is associated with colitis and with defects in immune cell recruitment to the lung.;Species reactivity: Mouse;Application: ELISA;Assay info: ;Sensitivity: < 6.0pg/mL

Mouse CXCL1/GROα ELISA kit (4X96T)
LF-EK50474 4×96T
EUR 2641.2

Anti-GRO alpha/Cxcl1 Antibody
A00533 100ug/vial
EUR 352.8

Anti-GRO alpha/CXCL1 Antibody
PA1760 100ug/vial
EUR 352.8

CXCL1 Antibody
43679-100ul 100ul
EUR 302.4

CXCL1 antibody
70R-10502 50 ug
EUR 560.4
Description: Affinity purified rabbit polyclonal CXCL1 antibody

CXCL1 antibody
70R-14297 100 ug
EUR 392.4
Description: Affinity purified Rabbit polyclonal CXCL1 antibody

CXCL1 antibody
70R-16681 50 ul
EUR 522
Description: Rabbit polyclonal CXCL1 antibody

CXCL1 antibody
70R-15473 100 ug
EUR 392.4
Description: Rabbit polyclonal CXCL1 antibody

CXCL1 Antibody
33054-100ul 100ul
EUR 302.4

CXCL1 Antibody
1-CSB-PA006239GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against CXCL1. Recognizes CXCL1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC

CXCL1 Antibody
1-CSB-PA06097A0Rb
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against CXCL1. Recognizes CXCL1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA

CXCL1 Antibody
1-CSB-PA009036
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against CXCL1. Recognizes CXCL1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/10000

Cxcl1 Antibody
1-CSB-PA09217A0Rb
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against Cxcl1. Recognizes Cxcl1 from Mouse. This antibody is Unconjugated. Tested in the following application: ELISA

GRO-alpha/CXCL1 (CHO-expressed), Mouse
HY-P7186 50ug
EUR 404.4

Cxcl1 sgRNA CRISPR Lentivector set (Mouse)
K4368201 3 x 1.0 ug
EUR 406.8

Mouse Growth-regulated alpha protein (Cxcl1)
1-CSB-RP092174m
  • EUR 606.00
  • EUR 318.00
  • EUR 2192.40
  • EUR 919.20
  • EUR 1461.60
  • EUR 402.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Mouse Growth-regulated alpha protein(Cxcl1),partial expressed in E.coli

CXCL1 Protein Vector (Mouse) (pPM-C-HA)
PV169144 500 ng
EUR 723.6

Cxcl1 ELISA Kit (Mouse) : 96 Wells (OKEH02714)
OKEH02714 96 Wells
EUR 652.8
Description: Description of target: This gene encodes a protein that is a member of the CXC subfamily of chemokines. Chemokines, which recruit and activate leukocytes, are classified by function (inflammatory or homeostatic) or by structure. This secretory protein is proposed to bind the G-protein coupled receptor chemokine (C-X-C motif) receptor 2 to recruit neutrophils. In mouse, deficiency of this gene is associated with colitis and with defects in immune cell recruitment to the lung. ;Species reactivity: Mouse;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 15.76 pg/mL

CXCL1 Protein Vector (Mouse) (pPB-C-His)
PV169142 500 ng
EUR 723.6

CXCL1 Protein Vector (Mouse) (pPB-N-His)
PV169143 500 ng
EUR 723.6

CXCL1 Protein Vector (Mouse) (pPM-C-His)
PV169145 500 ng
EUR 723.6

Nori® Mouse CXCL1/GRO-alpha ELISA Kit
GR117324 96-well
EUR 461

CXCL1 antibody (HRP)
60R-2236 100 ug
EUR 392.4
Description: Rabbit polyclonal CXCL1 antibody (HRP)

Rabbit Anti Rat Cxcl1 Polyclonal Antibody
CPBT-65101RR 0.1 mg
EUR 1057.2

CXCL1 antibody (FITC)
60R-2237 100 ug
EUR 392.4
Description: Rabbit polyclonal CXCL1 antibody (FITC)

CXCL1/GRO
EF012822 96 Tests
EUR 826.8

CXCL1/GRO
E21-597 10ug
EUR 411.6

Cxcl1 sgRNA CRISPR Lentivector (Mouse) (Target 1)
K4368202 1.0 ug DNA
EUR 184.8

Cxcl1 sgRNA CRISPR Lentivector (Mouse) (Target 2)
K4368203 1.0 ug DNA
EUR 184.8

Cxcl1 sgRNA CRISPR Lentivector (Mouse) (Target 3)
K4368204 1.0 ug DNA
EUR 184.8

CXCL1 antibody (biotin)
60R-2238 100 ug
EUR 392.4
Description: Rabbit polyclonal CXCL1 antibody (biotin)

CXCL1 siRNA
20-abx913248
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

CXCL1 siRNA
20-abx913249
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

CXCL1 siRNA
20-abx901350
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

pEGFP- CXCL1
PVT10178 2 ug
EUR 361.2

CXCL1 protein
30R-3156 50 ug
EUR 308.4
Description: Purified recombinant CXCL1 protein

CXCL1 Peptide
42-129P 0.1 mg
EUR 405.6
Description: (CT) CXCL1 Peptide

CXCL1 Conjugated Antibody
C33054 100ul
EUR 476.4

Cxcl1 Polyclonal Antibody
A51950
  • EUR 684.66
  • EUR 117.70
  • EUR 302.50
  • EUR 423.50
  • 100 µg
  • 20 ul
  • 50 ul
  • 100 ul

CXCL1 Polyclonal Antibody
A51978
  • EUR 684.66
  • EUR 117.70
  • EUR 302.50
  • EUR 423.50
  • 100 µg
  • 20 ul
  • 50 ul
  • 100 ul

CXCL1 Chemi-Luminescent ELISA Kit (Mouse) (OKCD03823)
OKCD03823 96 Wells
EUR 1232.4
Description: Description of target: Has chemotactic activity for neutrophils. Contributes to neutrophil activation during inflammation . Hematoregulatory chemokine, which, in vitro, suppresses hematopoietic progenitor cell proliferation. KC(5-72) shows a highly enhanced hematopoietic activity.;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 15.6 pg/mL

Mouse Cxcl1/ Growth-regulated alpha protein ELISA Kit
E0354Mo 1 Kit
EUR 655.2

Mouse Growth regulated alpha protein, Cxcl1 ELISA KIT
ELI-04012m 96 Tests
EUR 1038

GRO alpha (CXCL1) Antibody
abx018005-100ug 100 ug
EUR 410.4

Gro alpha Antibody / CXCL1
RQ4031 100 ug
EUR 356.15
Description: CXCL1 (Chemokine, CXC motif, Ligand 1), also called GRO1, SCYB1, GROA or MGSA, is a small cytokine belonging to the CXC chemokine family that was previously called GRO1 oncogene, GRO?, KC, Neutrophil-activating protein 3 (NAP-3) and melanoma growth stimulating activity, alpha (MSGA-?). In humans, this protein is encoded by the CXCL1 gene. The CXCL1 gene is mapped on 4q13.3. CXCL1 is secreted by human melanoma cells, has mitogenic properties and is implicated in melanoma pathogenesis. It is expressed by macrophages, neutrophils and epithelial cells, and has neutrophil chemoattractant activity. CXCL1 plays a role in spinal cord development by inhibiting the migration of oligodendrocyte precursors and is involved in the processes of angiogenesis, inflammation, wound healing, and tumorigenesis. Signaling through Cxcr2, Cxcl1 inhibited oligodendrocyte precursor migration. The migrational arrest was rapid, reversible, and concentration dependent, and it reflected enhanced cell/substrate interactions. White matter expression of Cxcl1 was temporospatially regulated. Others contribute to aggressive growth selectivity in the lung. Among the lung metastasis signature genes identified, several, including CXCL1, were functionally validated.

Mouse Growth-Regulated Alpha Protein (CXCL1) ELISA Kit
abx253956-96tests 96 tests
EUR 801.6

Mouse Growth-Regulated Alpha Protein (CXCL1) ELISA Kit
20-abx154438
  • EUR 6373.20
  • EUR 3404.40
  • EUR 801.60
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Mouse Growth-Regulated Alpha Protein (CXCL1) ELISA Kit
abx050043-96tests 96 tests
EUR 924

Mouse Growth-Regulated Alpha Protein (CXCL1) ELISA Kit
abx574645-96tests 96 tests
EUR 801.6

Mouse CXCL1/GROα(Growth Regulated Oncogene Alpha) ELISA Kit
EM0003 96T
EUR 571.5
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Mus ;Sensitivity: 9.375pg/ml

CXCL1 Antibody, HRP conjugated
1-CSB-PA06097B0Rb
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against CXCL1. Recognizes CXCL1 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

Cxcl1 Antibody, HRP conjugated
1-CSB-PA09217B0Rb
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against Cxcl1. Recognizes Cxcl1 from Mouse. This antibody is HRP conjugated. Tested in the following application: ELISA

CXCL1 Antibody, FITC conjugated
1-CSB-PA06097C0Rb
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against CXCL1. Recognizes CXCL1 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

Cxcl1 Antibody, FITC conjugated
1-CSB-PA09217C0Rb
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against Cxcl1. Recognizes Cxcl1 from Mouse. This antibody is FITC conjugated. Tested in the following application: ELISA

CXCL1 Antibody, Biotin conjugated
1-CSB-PA06097D0Rb
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against CXCL1. Recognizes CXCL1 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

Cxcl1 Antibody, Biotin conjugated
1-CSB-PA09217D0Rb
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against Cxcl1. Recognizes Cxcl1 from Mouse. This antibody is Biotin conjugated. Tested in the following application: ELISA

Recombinant Mouse CXCL1/ GRO-alpha Protein, Untagged, E.coli-1mg
QP1455-1mg 1mg
EUR 3427.2

Recombinant Mouse CXCL1/ GRO-alpha Protein, Untagged, E.coli-5ug
QP1455-5ug 5ug
EUR 163.2

Recombinant Mouse CXCL1/ GRO-alpha Protein, Untagged, E.coli-20ug
QP1455-20ug 20ug
EUR 284.4

Mouse Growth Regulated Oncogene Alpha / GROa (CXCL1) CLIA Kit
abx196070-96tests 96 tests
EUR 990

CXCL1 cloning plasmid
CSB-CL006239HU-10ug 10ug
EUR 279.6
Description: A cloning plasmid for the CXCL1 gene.

Recombinant Mouse CXCL1/ MGSA/ NAP-3 Protein, His, E.coli-1mg
QP8650-ec-1mg 1mg
EUR 2763.6

Recombinant Mouse CXCL1/ GRO-alpha Protein, Untagged, E.coli-100ug
QP1455-100ug 100ug
EUR 588

Recombinant Mouse CXCL1/ GRO-alpha Protein, Untagged, E.coli-500ug
QP1455-500ug 500ug
EUR 2133.6

CXCL1 Blocking Peptide
20-abx061039
  • EUR 343.20
  • EUR 510.00
  • 1 mg
  • 5 mg

CXCL1 Blocking Peptide
33R-7741 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CXCL1 antibody, catalog no. 70R-10502

Recombinant Mouse CXCL1/ MGSA/ NAP-3 Protein, His, E.coli-10ug
QP8650-ec-10ug 10ug
EUR 326.4